TTNP TITAN PHARMACEUTICALS INC Company Mergers 8-K Filing 2023 - Asset Purchase Agreement Titan Pharmaceuticals has entered into an asset purchase agreement with Fedson for the sale of certain ProNeura assets, including their drug addiction products, for an upfront purchase price of $2 million with potential milestone payments of up to $50 million on future net sales of the products.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC